Skip to main navigation Skip to search Skip to main content

Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health

  • Andrés Aranda-Díaz
  • , Eric Neubauer Vickers
  • , Kathryn Murie
  • , Brian Palmer
  • , Nicholas Hathaway
  • , Inna Gerlovina
  • , Simone Boene
  • , Manuel García-Ulloa
  • , Pau Cisteró
  • , Thomas Katairo
  • , Francis Ddumba Semakuba
  • , Bienvenu Nsengimaana
  • , Hazel Gwarinda
  • , Carla García-Fernández
  • , William Louie
  • , Endashaw Esayas
  • , Clemente Da Silva
  • , Debayan Datta
  • , Shahiid Kiyaga
  • , Innocent Wiringilimaana
  • Sindew Mekasha Feleke, Adam Bennett, Jennifer L. Smith, Endalamaw Gadisa, Jonathan B. Parr, Melissa D. Conrad, Jaishree Raman, Stephen Tukwasibwe, Isaac Ssewanyana, Eduard Rovira-Vallbona, Cristina M. Tato, Jessica Briggs, Alfredo Mayor, Bryan Greenhouse
  • University of California at San Francisco
  • Chan Zuckerberg Biohub
  • Centro de investigação de Saúde de Manhiça
  • Universitat de Barcelona
  • Infectious Diseases Research Collaboration
  • National Health Laboratory Services
  • Armauer Hansen Research Institute
  • Makerere University
  • The African Center of Excellence in Bioinformatics and Data Intensive Sciences
  • Ethiopia Public Health Institute
  • La Trobe University
  • PATH
  • University of North Carolina at Chapel Hill
  • University of the Witwatersrand
  • University of Pretoria
  • University of Barcelona
  • Universidade Eduardo Mondlane

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

Targeted amplicon sequencing is a powerful and efficient tool for interrogating the Plasmodium falciparum genome, generating actionable data from infections to complement traditional malaria epidemiology. For maximum impact, genomic tools should be multi-purpose, robust, sensitive, and reproducible. We developed, characterized, and implemented MAD4HatTeR, an amplicon sequencing panel based on Multiplex Amplicons for Drug, Diagnostic, Diversity, and Differentiation Haplotypes using Targeted Resequencing, along with a bioinformatic pipeline for data analysis. Additionally, we introduce an analytical approach to detect gene duplications and deletions from amplicon sequencing data. Laboratory control and field samples were used to demonstrate the panel’s high sensitivity and robustness. MAD4HatTeR targets 165 highly diverse loci, focusing on multiallelic microhaplotypes, key markers for drug and diagnostic resistance (including duplications and deletions), and CSP and potential vaccine targets. The panel can also detect non-falciparum Plasmodium species. MAD4HatTeR successfully generated data from low-parasite-density dried blood spot and mosquito midgut samples and detected minor alleles at within-sample allele frequencies as low as 1% with high specificity in high-parasite-density dried blood spot samples. Gene deletions and duplications were reliably detected in mono- and polyclonal controls. Data generated by MAD4HatTeR were highly reproducible across multiple laboratories. The successful implementation of MAD4HatTeR in five laboratories, including three in malaria-endemic African countries, showcases its feasibility and reproducibility in diverse settings. MAD4HatTeR is thus a powerful tool for research and a robust resource for malaria public health surveillance and control.

Original languageEnglish
Article number10737
JournalScientific Reports
Volume15
Issue number1
DOIs
Publication statusPublished - 28 Mar 2025
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antimalarial resistance
  • Complexity of infection
  • Csp
  • hrp2 deletion
  • Identity-by-descent
  • Malaria
  • Microhaplotype
  • Plasmodium falciparum
  • Targeted amplicon sequencing

Fingerprint

Dive into the research topics of 'Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health'. Together they form a unique fingerprint.

Cite this